Summary
Elevance Health, Inc. (ELV) issued a Current Report (8-K) on September 20, 2023, primarily to reaffirm its financial guidance for the full year 2023. The company expects net income to be greater than $29.09 per share. This figure includes approximately $3.76 per share of net unfavorable items. Excluding these specific unfavorable items, Elevance Health maintains its expectation for adjusted net income to exceed $32.85 per share. This guidance remains consistent with information previously provided in the company's second quarter 2023 earnings release and does not account for any additional adjustment items beyond those already reported.
Key Highlights
- 1Elevance Health reaffirms its full-year 2023 net income guidance to be greater than $29.09 per share.
- 2The company expects approximately $3.76 per share in net unfavorable items for full-year 2023.
- 3Adjusted net income guidance for full-year 2023 remains greater than $32.85 per share, excluding specific unfavorable items.
- 4The reaffirmed guidance does not include any new or additional adjustment items beyond those reported in the Q2 2023 earnings release.
- 5This filing serves as a reaffirmation of previous financial outlooks shared with investors.
- 6The report includes standard forward-looking statement disclaimers and outlines various risks and uncertainties the company faces.
Frequently Asked Questions
The primary purpose of this 8-K filing is to reaffirm Elevance Health's full-year 2023 financial guidance to investors during upcoming meetings. It confirms previously issued net income and adjusted net income per share expectations.
Elevance Health expects its net income for the full year 2023 to be greater than $29.09 per share. This guidance is subject to approximately $3.76 per share of net unfavorable items.
Excluding the identified net unfavorable items, Elevance Health continues to expect adjusted net income to be greater than $32.85 per share. This guidance does not incorporate any new adjustment items beyond those already disclosed in the company's second quarter 2023 earnings release.
No, this 8-K filing is focused on financial guidance reaffirmation. It does not announce any new operational developments, strategic changes, or material business events. It includes standard disclosures about forward-looking statements and associated risks.